Skip to content
Screener

AdaptHealth AHCO Q2 2026 earnings

Reported August 4, 2026 · Before market open

Revenue$740.3MMiss by $106.5M
EPS$0.06Miss by $0.11
Revenue estimate$846.8M
EPS estimate$0.17
“In the second quarter, we delivered 15.9% organic growth, with record volume gains across the business. Also, in July we signed a definitive agreement to divest our Diabetes Health business, the most significant step yet in our multi-year effort to focus AdaptHealth on our core Sleep Health, Respiratory Health, and supporting Wellness-at-Home businesses. Our West Coast capitated partnership reached full scale in the quarter, and the complexity of that transition has impacted our margins. Together with an unexpected price increase from one of our manufacturers, this has led us to lower our full-year outlook. We are moving quickly to address the cost pressures introduced by our rapid growth, and we believe these actions will make us a stronger, more efficient company.”
Suzanne Foster

Next report

Nov 3, 2026 (Tomorrow)
Revenue estimate$725.9M
EPS estimate-$0.05

Financials

Q2 2026

Income statement

See full
Revenue$740.3M+12.7%
Gross profit$104.2M-23.3%
Operating income-$137.8M-310%
Net income-$133.9M-1,013%
EPS (diluted)-$0.99-1,090%

Balance sheet

See full
Total debt$2.1B+5.9%
Total equity$1.4B-13.2%
Total assets$4.3B-0.2%

Cash flow

See full
Operating cash flow$145.3M-10.3%
CapEx$166.2M+87.5%
Free cash flow-$20.9M-129%

Valuation & ratios

Valuation

as of 10/30/26
See full
Market cap$791.12M-34.7%
P/S0.3×-0.1×

Profitability

See full
Gross margin17%-2.7pp
Net margin-7.1%-9.7pp
FCF margin3%-4.4pp

Returns & leverage

See full
Return on equity-15.4%-20.6pp
Debt / equity1.5×+0.3×
Current ratio1.1×+0.1×

Segments

By segment

See full
Sleep Health$386.5M+15.5%
Respiratory Health$194.4M+14.1%
Wellness at Home$159.4M+4.9%

Versus estimates

Revenue

Q2 2026$740.3MMiss by $106.5M
Q2 2026$819.8MBeat by $23.2M
Q4 2025$846.3MBeat by $14.7MQ3 2025$820.3MMiss by $12.2MQ2 2025$800.4MBeat by $1.2MQ1 2025$580.5MMiss by $227.7M

Diluted EPS

Q2 2026$0.06Miss by $0.11
Q2 2026-$0.06Miss by $0.07
Q4 2025$0.27Miss by $0.07Q3 2025$0.22Miss by $0.02Q2 2025$0.01Miss by $0.14Q1 2025$0.01In line

FAQ

When did AdaptHealth report Q2 2026 earnings?
AdaptHealth (AHCO) reported Q2 2026 earnings on August 4, 2026 before market open.
What were AdaptHealth's Q2 2026 revenue and EPS?
AdaptHealth reported revenue of $740.3M and eps of $0.06 for Q2 2026.
Did AdaptHealth beat estimates in Q2 2026?
Revenue missed the consensus estimate of $846.8M by $106.5M. EPS missed the consensus estimate of $0.17 by $0.11.
How did AdaptHealth's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 7.5% from $800.4M a year earlier and eps grew 500.0% from $0.01.
Where can I find AdaptHealth's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-052149) and the 10-Q periodic report (0001628280-26-052646) directly on SEC EDGAR. The filing index links above go to sec.gov.